What EUROLEN is
EUROLEN contains the active substance ‘lenalidomide’. This medicine belongs to a group of medicines which affect how your immune system works.
What EUROLEN is used for
EUROLEN is used in adults for:
- Myelodysplastic syndromes (MDS)
- Multiple myeloma
Myelodysplastic syndromes (MDS)
MDS are a collection of many different blood and bone marrow diseases. The blood cells become abnormal and do not function properly. Patients can experience a variety of signs and symptoms including a low red blood cell count (anemia), the need for a blood transfusion, and be at risk of infection.
EUROLEN is used alone to treat adult patients who have been diagnosed with MDS, when all of the following apply:
- you need regular blood transfusions to treat low levels of red blood cells (‘transfusion-dependent anaemia’)
- you have an abnormality of cells in the bone marrow called an ‘isolated deletion 5q cytogenetic abnormality’. This means your body does not make enough healthy blood cells
- other treatments have been used before, are not suitable or do not work well enough.
EUROLEN can increase the number of healthy red blood cells that the body produces by reducing the number of abnormal cells:
- this can reduce the number of blood transfusions needed. It is possible that no transfusions will be needed.
Multiple myeloma
Multiple myeloma is a type of cancer, which affects a certain kind of white blood cell, called the plasma cell. These cells collect in the bone marrow and divide, becoming out of control. This can damage the bones and kidneys.
EUROLEN is taken together with an anti-inflammatory medicine called ‘dexamethasone’. EUROLEN can stop the signs and symptoms of multiple myeloma getting worse. It has also been shown to delay multiple myeloma from coming back following treatment.